Research Frontiers (NASDAQ:REFR – Get Free Report) issued its earnings results on Thursday. The technology company reported ($0.01) earnings per share (EPS) for the quarter, FiscalAI reports. Research Frontiers had a negative net margin of 344.56% and a negative return on equity of 168.54%. The firm had revenue of $0.08 million during the quarter.
Here are the key takeaways from Research Frontiers’ conference call:
- Gauzy’s court-approved settlement and October financing have enabled initial payments to support restarting SPD emulsion production in Israel and film manufacturing in Germany. Research Frontiers said the next tests are consistent output, quality and delivery, while noting the French proceedings remain unresolved.
- Supply constraints weighed heavily on results: third-quarter fee income fell to about $77,000 from $359,000 a year earlier, and the net loss widened to approximately $510,000. Research Frontiers had about $645,000 in cash at quarter-end and does not expect a material royalty recovery until after the fourth quarter of 2026; it also depends on partners for manufacturing.
- The company cited continued automotive and aerospace opportunities despite the supply disruption, including existing programs with four automakers and a newly started project with a North American aircraft manufacturer. These prospects still depend on restoring reliable film supply and converting development activity into production and sales.
- Management sees architectural retrofit as a potentially significant growth opportunity because it targets existing buildings and could move from purchase decision to installation faster than new-construction projects. Commercial rollout was delayed by the film shortage and depends on qualified supply, project economics and installation partners.
- Research Frontiers does not currently qualify for Nasdaq’s automatic 180-day bid-price extension because it also fails another listing requirement. The board is considering whether to seek a hearing in December and other options; management said it hopes to avoid a reverse stock split.
Research Frontiers Trading Down 4.2%
Research Frontiers stock traded down $0.02 during mid-day trading on Thursday, hitting $0.37. 37,376 shares of the company’s stock traded hands, compared to its average volume of 102,773. The firm has a 50 day simple moving average of $0.53 and a two-hundred day simple moving average of $0.73. Research Frontiers has a fifty-two week low of $0.33 and a fifty-two week high of $2.10.
Hedge Funds Weigh In On Research Frontiers
An institutional investor recently bought a new position in Research Frontiers stock. BlackRock Inc. acquired a new stake in Research Frontiers Incorporated (NASDAQ:REFR – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 532,542 shares of the technology company’s stock, valued at approximately $277,000. BlackRock Inc. owned 1.53% of Research Frontiers at the end of the most recent reporting period. Institutional investors and hedge funds own 11.91% of the company’s stock.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Research Frontiers in a research report on Monday, September 21st. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock presently has an average rating of “Sell”.
View Our Latest Analysis on Research Frontiers
Research Frontiers Company Profile
Research Frontiers, Inc (NASDAQ: REFR) develops and licenses technology for electronically controlled glass and other light-control products. Its principal technology, known as SPD-SmartGlass, uses suspended particles to regulate the amount of light passing through a window or panel. The technology can be used to provide variable tinting, glare control, solar heat management and privacy.
Research Frontiers generally operates as a licensing and technology-development company rather than as a manufacturer of finished glass products.
Read More
- Five stocks we like better than Research Frontiers
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Research Frontiers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Frontiers and related companies with MarketBeat.com's FREE daily email newsletter.
